Schwabe World-wide

 

From modest beginnings, our company has grown to be an enterprise of international standing.
Dr. Willmar Schwabe Pharmaceuticals aims at further strengthening its leading position in the research, development and marketing of phytopharmaceuticals, ultimately benefiting customers and achieving commercial success.

The Schwabe group comprises several companies in Germany as well as more than 20 subsidiaries and joint ventures around the world.

To find out more about Schwabe's global presence, please click on the map below.

Our company’s share in the European, Asian and American markets has been increasing since the 1980s. International business represents roughly half of the total group turnover and contributes significantly to the company’s growth strategy. The Schwabe Group is presently expanding its marketing activities in five continents.

Regulatory requirements are a major factor in determining the amount of time and expense related to the successful development and marketing of a product.
We are experts at adapting to the changing regulatory needs and have achieved more than 800 drug registrations world-wide.

Today, our products are available in over 60 countries either through Schwabe’s own companies and joint ventures or through licence partners.